Symptoms and immunologic markers induced by exposure to methyltetrahydrophthalic anhydride.
A study was performed in 43 workers exposed to methyltetrahydrophthalic anhydride (MTHPA) used as a hardener in an epoxy resin system. Ten workers sensitized to MTHPA (group SS; presence of serum IgE antibodies against a conjugate of MTHPA and human serum albumin (HSA) detected by RAST) had significantly higher levels of tryptase in nasal lavage fluid than 19 nonsensitized workers with work-related nasal symptoms (group NS) and 14 nonsensitized workers without nasal symptoms (group NN). This suggests an ongoing mast-cell-mediated reaction in the sensitized group. No statistically significant differences were found in the three groups concerning eosinophil cationic protein (ECP) and TAME-activity in lavage fluid. However, there was a significant increase in serum ECP in the SS group, as compared with a group of unexposed controls. Nasal challenge with MTHPA-HSA, performed in a subsequent study in seven workers from the SS group, six from the NS group, and seven from the NN, caused a larger increase of symptom score and a more pronounced decrease in nasal inspiratory peak flow in the SS group than in the other two groups. No significant rise was recorded for tryptase and ECP in lavage fluid in any of the three groups after challenge. The combined results of the two studies indicate that specific IgE antibodies play a pathogenetic role in at least some of the cases of work-related nasal symptoms associated with MTHPA exposure.
Department of Occupational and Environmental Medicine, University Hospital, Lund, Sweden.
J
J
Nielsen
H
H
Welinder
I
I
Bensryd
P
P
Andersson
S
S
Skerfving
D001798:Blood Proteins / Q000032:analysis; D053818:Chymases; D047091:Eosinophil Granule Proteins; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D017817:Nasal Lavage Fluid / Q000737:chemistry; D009299:Nasal Provocation Tests; D009784:Occupational Diseases / Q000139:chemically induced / Q000276:immunology* / Q000503:physiopathology; D010796:Phthalic Anhydrides / Q000009:adverse effects*; D011852:Radioallergosorbent Test; D012130:Respiratory Hypersensitivity / Q000139:chemically induced / Q000276:immunology* / Q000503:physiopathology; D012260:Ribonucleases; D012697:Serine Endopeptidases / Q000032:analysis; D012709:Serum Albumin / Q000032:analysis; D014106:Tosylarginine Methyl Ester / Q000032:analysis; D053802:Tryptases
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D007074:Immunoglobulin G; D010796:Phthalic Anhydrides; D012709:Serum Albumin; C088343:methyltetrahydrophthalic anhydride; D007073:Immunoglobulin E; D014106:Tosylarginine Methyl Ester; D012260:Ribonucleases; D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; D053802:Tryptases